High levels of FGL2 in GBM have been shown to induce immunosuppression through up-regulation of programmed cell death protein 1 (PD-1) and ectonucleoside triphosphate diphosphohydrolase 1, also known as CD39 [186]. The gene discussed is FGL2; the disease is glioblastoma.